Company intelligence / Profile preview

JuvaPlus

Geneva, Geneva, Switzerland

Ownership: Private
Employees: ~20
Development stage: Other

Overview

JuvaPlus is a Swiss medical technology company specializing in the development of high-precision motorized injection devices for aesthetic medicine. The company's flagship product, Juvapen, is a cordless, motorized syringe designed specifically for the delivery of botulinum toxin, offering unparalleled accuracy and consistency compared to manual injections. By automating the injection process, JuvaPlus aims to reduce patient pain, minimize side effects like bruising, and ensure reproducible results for practitioners. The company targets the global dermatology and plastic surgery markets, focusing on both cosmetic and therapeutic applications of neurotoxins.

Therapeutic areas: DermatologyNeurology
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on JuvaPlus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on JuvaPlus.

Explore the full profile